CGT supply chain orchestration: a how-to guide

About a year and a half ago, we were asked by a client in the US to help them implement capacity planning & detailed scheduling for manufacturing and quality operations in a CAR-T cell & gene therapy production plant.

What are the insights that we have gained since then? And what have we discovered as game-changing elements in the end-to-end supply chain orchestration? You will discover it in Geert’s presentation.

Key takeaways

  • In this new market, demand is exploding but supply chain is immature
  • There’s a mind shift towards a new kind of supply chain, with a lot of moving parts
  • Need to be extremely agile and be able to react in real-time to volatilities in the supply chain

Watch now for free

A stylized helix of DNA, illustrating the topic of this video: Cell and gene therapy CGT supply chain orchestration

These resources might interest you

  • A photo of the white paper

    Industrializing the next generation of cell and gene therapies

    Download now
  • Photo of the cover of the white paper

    Scaling CGT supply chains: from clinical to commercial

    Managing and scaling CGT supply chains and manufacturing operations is one of the biggest challenges. Our expert panel discusses solutions.
    Download now
  • Scientist in a clean room laboratory reviewing documentation for a bioreactor, representing our autologous therapy slot allocation case study

    How to tackle manufacturing planning for cell and gene therapy?

    Are you looking for cell and gene therapy software to manage your manufacturing plans? Binocs is specifically designed for CGT—read more!
    Read more